PembrolizumabRhabdomyolysis and myositis: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1707卷 / 1期

关键词：

D O I：

10.1007/s40278-018-48040-1

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：224 / 224

相关论文

共 50 条

[31] CamrelizumabMyocarditis and myositis: case report
Reactions Weekly, 2023, 1975 (1) : 92 - 92
[32] AdalimumabLupus myositis: case report
Reactions Weekly, 2012, 1400 (1) : 6 - 6
[33] PembrolizumabOrbital myositis: case report
Reactions Weekly, 2024, 2025 (1) : 391 - 391
[34] AtorvastatinAutoimmune myositis: case report
Reactions Weekly, 2020, 1817 (1) : 70 - 70
[35] TozinameranInflammatory myositis: case report
Reactions Weekly, 2023, 1974 (1) : 331 - 331
[36] DurvalumabFulminant myositis: case report
Reactions Weekly, 2024, 2030 (1) : 175 - 175
[37] AdalimumabLupus myositis: case report
Reactions Weekly, 2012, 1394 (1) : 5 - 5
[38] AtorvastatinNecrotising myositis: case report
Reactions Weekly, 2025, 2048 (1) : 62 - 62
[39] GolimumabGranulomatous myositis: case report
Reactions Weekly, 2020, 1789 (1) : 138 - 138
[40] AtorvastatinNecrotising myositis: case report
Reactions Weekly, 2022, 1899 (1) : 66 - 66

← 1 2 3 4 5 →